rcca-header
Clinical Trials

A Phase 2 Multicenter Study Evaluating the Efficacy of KTE-C19 in Subjects with Relapsed/Refractory Mantle Cell Lymphoma (r/r MCL)

Type of Cancer
Lymphoma
Site
Hackensack
Sponsor
Kite Pharma
Protocol Number
Kite Pharma KTE-C19-102
To Learn More Call
(201)-510-0950